Back to search results

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Abroad (travel likely)RecruitingPHASE2

Conditions

B-Cell Lymphoblastic Leukemia · Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Principal Investigator (Bijal D. Shah, MD)
    Rawan Faramand, MD (Sub-investigator)
    Leidy Isenalumhe, MD (Sub-investigator)
    Frederick Locke, MD (Sub-investigator)
Study leads

  • Bijal D. Shah, MD

    Principal Investigator

    Moffitt Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)